Skip to main content
logo
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
29.46
-0.18 (-0.61%)
At close: Jun 5, 2026, 4:00 PM EDT
29.35
-0.11 (-0.37%)
After-hours: Jun 5, 2026, 6:49 PM EDT

Cue Biopharma Revenue

Cue Biopharma had revenue of $5.69M in the quarter ending March 31, 2026, with 1,250.59% growth. This brings the company's revenue in the last twelve months to $32.73M, up 309.60% year-over-year. In the year 2025, Cue Biopharma had annual revenue of $27.47M with 195.75% growth.

Revenue (ttm)
$32.73M
Revenue Growth
+309.60%
P/S Ratio
2.82
Revenue / Employee
$1,128,655
Employees
29
Market Cap
95.90M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.47M18.18M195.75%
Dec 31, 20249.29M3.80M69.16%
Dec 31, 20235.49M4.25M340.96%
Dec 31, 20221.25M-13.70M-91.67%
Dec 31, 202114.94M11.79M373.68%
Dec 31, 20203.15M-304.00K-8.79%
Dec 31, 20193.46M2.32M202.67%
Dec 31, 20181.14M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Heron Therapeutics150.71M
Fortress Biotech66.16M
MindWalk Holdings20.70M
Outlook Therapeutics333.14K
Inovio Pharmaceuticals65.34K
Revenue Rankings

CUE News

More News